|
|
|
Volumn 13, Issue 5, 2002, Pages
|
|
FTC superiority over d4T in phase III trial.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE;
STAVUDINE;
ARTICLE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PHASE 3 CLINICAL TRIAL;
CLINICAL TRIALS, PHASE III;
DEOXYCYTIDINE;
HIV INFECTIONS;
HUMANS;
STAVUDINE;
|
|
EID: 3242885098
PISSN: 15232883
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
